REAL-WORLD EFFECTIVENESS OF BRENTUXIMAB VEDOTIN VS OTHER TREATMENTS IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA POST AUTOLOGOUS STEM-CELL TRANSPLANTATION

被引：0
作者：
Zagadailov, E. A. [1 ]
Corman, S. [2 ]
Hagan, M. [3 ]
Chirikov, V. [2 ]
Johnson, C. [2 ]
Macahilig, C. [3 ]
Sea, B. [1 ]
Dalal, M. R. [1 ]
Broeckelmann, P. J. [4 ,5 ]
Illidge, T. [6 ]
机构：
[1] Millennium Pharmaceut Inc, Cambridge, MA USA
[2] Pharmerit Int, Bethesda, MD USA
[3] Med Data Analyt, Parsippany, NJ USA
[4] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany
[5] Univ Hosp Cologne, GHSG, Cologne, Germany
[6] Univ Manchester, Inst Canc Sci, Christie Hosp, Manchester, Lancs, England
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P094
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [31] Brentuximab vedotin in association with bendamustine in refractory or multiple relapsed Hodgkin lymphoma. A retrospective real-world study
    Iannitto, Emilio
    Romano, Alessandra
    Scalzulli, Potito Rosario
    Bonanno, Vincenza
    Scalone, Renato
    Chiarenza, Annalisa
    Pirosa, Maria Cristina
    Caruso, Anastasia Laura
    Minoia, Carla
    Mantuano, Saverio
    De Santis, Gaetano
    Salerno, Marilena
    Crescimanno, Alessandra
    Porretto, Ferdinando
    Li Gioi, Felicina
    Ricciuti, Giuseppina
    Greco, Antonino
    Pavone, Enzo
    Guarini, Attilio
    Tarantini, Giuseppe
    Mannina, Donato
    Consoli, Ugo
    Cascavilla, Nicola
    Di Raimondo, Francesco
    Musso, Maurizio
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (06) : 581 - 587
  • [32] Autologous stem cell transplantation in refractory or relapsed Hodgkin lymphoma
    Afonso, S.
    Carvalhais, I.
    Carneiro, A.
    Araujo, J.
    Principe, F.
    Guimaraes, J. E.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S440 - S441
  • [33] Outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin lymphoma patients in a centre from Turkey
    Sucak, Gulsan Turkoz
    Cakar, Merih Kizil
    Suyani, Elif
    Aki, Zeynep
    Altindal, Sermin
    Acar, Kadir
    HEMATOLOGY, 2013, 18 (05) : 269 - 276
  • [34] Brentuximab vedotin compared with other therapies in relapsed/refractory Hodgkin lymphoma post autologous stem cell transplant: median overall survival meta-analysis
    Bonthapally, Vijayveer
    Yang, Hongbo
    Ayyagari, Rajeev
    Tan, Ruo-Ding
    Cai, Sean
    Wu, Eric
    Gautam, Ashish
    Chi, Andy
    Huebner, Dirk
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (07) : 1377 - 1389
  • [35] IMPROVED SURVIVAL OUTCOMES OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN RELAPSED/REFRACTER HODGKIN'S LYMPHOMA IN THE BRENTUXIMAB VEDOTIN ERA REAL WORLD DATA FROM HUNGARY
    Miltenyi, Zsofia
    Husi, Kata
    Szabo, Roxana
    Pinczes, Laszlo Imre
    Foldeak, Dora
    Dudley, Reka
    Szomor, Arpad
    Koller, Beata
    Gopcsa, Laszlo
    Illes, Arpad
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 458 - 459
  • [36] THE COST-EFFECTIVENESS OF NIVOLUMAB FOR THE TREATMENT OF PEOPLE WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANT AND BRENTUXIMAB VEDOTIN
    Jones, B.
    Ward, T.
    Harrison, J. P.
    Hurst, M.
    Tyas, D.
    McEwan, P.
    Gordon, J.
    VALUE IN HEALTH, 2017, 20 (09) : A433 - A433
  • [37] Outcomes of Refractory and Relapsed Hodgkin Lymphoma With Autologous Stem-Cell Transplantation: A Single Institution Experience
    Wali, Rabia
    Saeed, Haleema
    Patrus, Naveed
    Javed, Shehla
    Khan, Saadiya Javed
    JOURNAL OF GLOBAL ONCOLOGY, 2019, 5 : 1 - 6
  • [38] Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation For Relapsed/Refractory Hodgkin Lymphoma In The Brentuximab Vedotin Era
    Anderlini, Paolo
    Saliba, Rima
    Ledesma, Celina
    Chancoco, Christina M.
    Alexander, Tamera R.
    Alousi, Amin M.
    Hosing, Chitra
    Khouri, Issa F.
    Nieto, Yago
    Popat, Uday R.
    Shpall, Elizabeth J.
    Fanale, Michelle A.
    Oki, Yasuhiro
    Romaguera, Jorge E.
    Neelapu, Sattva S.
    Younes, Anas
    Champlin, Richard E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S72 - S72
  • [39] High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphoma
    Park, Kwonoh
    Yoon, Dok Hyun
    Kim, Shin
    Park, Chan-Sik
    Huh, Jooryung
    Lee, Sang-Wook
    Suh, Cheolwon
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (02) : 256 - 262
  • [40] High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphoma
    Kwonoh Park
    Dok Hyun Yoon
    Shin Kim
    Chan-Sik Park
    Jooryung Huh
    Sang-Wook Lee
    Cheolwon Suh
    International Journal of Hematology, 2013, 97 : 256 - 262
12345